Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnostic Agent Adverse Reaction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05221333
What this trial is testing

Sorrel 25R Injector - Sorrel Clinical Study Protocol

Who this might be right for
Injection SiteInjection Site ReactionInjection Site Irritation
Eitan Medical 20
Testing effectiveness (Phase 2)Study completedNCT00333736
What this trial is testing

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 337
Not applicableStudy completedNCT05091931
What this trial is testing

Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting

Who this might be right for
Urinary Tract Infections
Pathnostics 3,308
Testing effectiveness (Phase 2)Looking for participantsNCT07654426
What this trial is testing

The CARDIOPROTECT Trial

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
Beth Israel Deaconess Medical Center 60
Not applicableStudy completedNCT01271608
What this trial is testing

Study to Evaluate the Need of Needle Change for Application of Intramuscular, Subcutaneous and Intradermal Injection.

Who this might be right for
Knowledge, Attitudes, PracticeInjection Site Reactions
Hospital M'Boi Mirim 1,240
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableActive Not RecruitingNCT07703748
What this trial is testing

Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

Who this might be right for
Human Immunodeficiency Virus Infection (HIV)HIV-1 Infection in Adults
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE 3,346
Not applicableStudy completedNCT06093815
What this trial is testing

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Who this might be right for
Injection Site Reaction
Merz North America, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00002827
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

Who this might be right for
Cardiac ToxicityLymphoma
Children's Oncology Group 294
Not applicableStudy completedNCT01407640
What this trial is testing

Diagnosis and Physiopathology of Insulin Allergy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Hypersensitivity+2 more
Assistance Publique - Hôpitaux de Paris 55
Post-approval studies (Phase 4)Study completedNCT05007041
What this trial is testing

Simultaneous RZV and aIIV4 Vaccination

Who this might be right for
PainQuality of LifeInjection Site Reaction+1 more
Duke University 267
Not applicableStudy completedNCT02839811
What this trial is testing

Medical Device for Drug Allergy Diagnosis

Who this might be right for
Drug Hypersensitivity
University Hospital, Montpellier 145
Testing effectiveness (Phase 2)Study completedNCT03963115
What this trial is testing

Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?

Who this might be right for
Injection Reactions SiteSystemic Reactions
Mahidol University 17
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Not applicableStudy completedNCT03645369
What this trial is testing

Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection

Who this might be right for
Injection Site ReactionInjection Site Bruising
Istanbul Saglik Bilimleri University 165
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Very early researchStudy completedNCT05775601
What this trial is testing

18F-LY3950321-01 Biodistribution and Safety Study

Who this might be right for
Diagnostic Agent Adverse ReactionRadiation Exposure
Avid Radiopharmaceuticals 6
Not applicableUnknownNCT04526548
What this trial is testing

A Diagnostic Study on Patients With Drug-induced Liver Injury

Who this might be right for
Acute Drug-induced Liver InjuryChronic Liver Disease
Drug Induced Liver Disease Study Group 600
Not applicableStudy completedNCT05508087
What this trial is testing

Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.

Who this might be right for
Cardiotoxicity
I.M. Sechenov First Moscow State Medical University 150
Next Page